Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

Eisai Co., Ltd.150 enrolled

Overview

Investigation of the clinical condition in patients with cervical dystonia by Toronto Western Spasmodic Torticollis Scale (TWSTRS)

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Cervical Dystonia

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion criteria: Patients with cervical dystonia who was treated by botulinum toxin type A in the past. Patients who was enrolled in NB01S and was evaluated by TWSTRS at the first injection of NerBloc.

Locations (2)

Unnamed facility

Osaka, Japan

Unnamed facility

Tokyo, Japan

Outcomes

Primary Outcomes

Whole improvement level

Toronto Western Spasmodic Torticollis Scale (TWSTRS)

Time frame: Up to 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.